{"id":"https://openalex.org/W7202091926","doi":"https://doi.org/10.1002/psp4.70322","title":"A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health","display_name":"A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7202091926","doi":"https://doi.org/10.1002/psp4.70322","pmid":"https://pubmed.ncbi.nlm.nih.gov/42572918","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13454951"},"language":"en","primary_location":{"id":"doi:10.1002/psp4.70322","doi":"https://doi.org/10.1002/psp4.70322","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.70322","pdf_url":null,"source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1002/psp4.70322","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082079518","display_name":"Igor Goryanin","orcid":"https://orcid.org/0000-0002-8293-774X","observed_orcids":["https://orcid.org/0000-0002-8293-774X"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Igor Goryanin","raw_affiliation_strings":["IQANOVA Ltd  Edinburgh UK","School of Informatics University of Edinburgh  Edinburgh UK"],"raw_orcid":"https://orcid.org/0000-0002-8293-774X","affiliations":[{"raw_affiliation_string":"IQANOVA Ltd  Edinburgh UK","institution_ids":[]},{"raw_affiliation_string":"School of Informatics University of Edinburgh  Edinburgh UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099166443","display_name":"Bob Damms","orcid":"https://orcid.org/0009-0000-4884-9431","observed_orcids":["https://orcid.org/0009-0000-4884-9431"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bob Damms","raw_affiliation_strings":["IQANOVA Ltd  Edinburgh UK"],"raw_orcid":"https://orcid.org/0009-0000-4884-9431","affiliations":[{"raw_affiliation_string":"IQANOVA Ltd  Edinburgh UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5125550270","display_name":"Irina Goryanin","orcid":"https://orcid.org/0009-0007-2340-1113","observed_orcids":["https://orcid.org/0009-0007-2340-1113"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Irina Goryanin","raw_affiliation_strings":["IQANOVA Ltd  Edinburgh UK","School of Informatics University of Edinburgh  Edinburgh UK"],"raw_orcid":"https://orcid.org/0009-0007-2340-1113","affiliations":[{"raw_affiliation_string":"IQANOVA Ltd  Edinburgh UK","institution_ids":[]},{"raw_affiliation_string":"School of Informatics University of Edinburgh  Edinburgh UK","institution_ids":["https://openalex.org/I98677209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5082079518"],"corresponding_institution_ids":["https://openalex.org/I98677209"],"apc_list":{"value":4140,"currency":"USD","value_usd":4140},"apc_paid":{"value":4140,"currency":"USD","value_usd":4140},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.56762705,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"8","first_page":"e70322","last_page":"e70322"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7929999828338623,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7929999828338623,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10676","display_name":"Genetics, Aging, and Longevity in Model Organisms","score":0.09040000289678574,"subfield":{"id":"https://openalex.org/subfields/1302","display_name":"Aging"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aging","display_name":"aging","score":0.9800000190734863},{"id":"https://openalex.org/keywords/quantitative-systems-pharmacology","display_name":"quantitative systems pharmacology","score":0.699999988079071},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8579999804496765},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9679999947547913},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8980000019073486},{"id":"https://openalex.org/keywords/metabolic-health","display_name":"metabolic health","score":0.6859999895095825},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.8930000066757202},{"id":"https://openalex.org/keywords/damage-accumulation","display_name":"damage accumulation","score":0.6190000176429749},{"id":"https://openalex.org/keywords/repair-capacity","display_name":"repair capacity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/gdf15","display_name":"GDF15","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.9419999718666077},{"id":"https://openalex.org/keywords/glucose-disposal-rate","display_name":"glucose disposal rate","score":0.6790000200271606},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8360000252723694},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7099999785423279},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5087000131607056},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.477400004863739},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.45739999413490295},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4422999918460846},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4043999910354614},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.40209999680519104},{"id":"https://openalex.org/C122770356","wikidata":"https://www.wikidata.org/wiki/Q1656753","display_name":"Identifiability","level":2,"score":0.3781000077724457},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.37299999594688416},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.36480000615119934},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.3637000024318695},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.3343999981880188},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.2969000041484833},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2935999929904938},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.28380000591278076},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2736000120639801},{"id":"https://openalex.org/C3017594256","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin sensitivity","level":4,"score":0.26660001277923584},{"id":"https://openalex.org/C2781452922","wikidata":"https://www.wikidata.org/wiki/Q2892805","display_name":"Proteostasis","level":2,"score":0.26649999618530273}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000091484","descriptor_name":"Network Pharmacology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/psp4.70322","doi":"https://doi.org/10.1002/psp4.70322","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.70322","pdf_url":null,"source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},{"id":"pmid:42572918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42572918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: pharmacometrics & systems pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13454951","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13454951/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT Pharmacometrics Syst Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1c51332d737a487cb57f59249834c043","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1c51332d737a487cb57f59249834c043","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology, Vol 15, Iss 8, Pp n/a-n/a (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/psp4.70322","doi":"https://doi.org/10.1002/psp4.70322","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.70322","pdf_url":null,"source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5705499053001404}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W44278768","https://openalex.org/W1998523300","https://openalex.org/W2125435699","https://openalex.org/W2135741828","https://openalex.org/W2146264128","https://openalex.org/W2149010238","https://openalex.org/W2150908245","https://openalex.org/W2158822657","https://openalex.org/W2164059021","https://openalex.org/W2168648059","https://openalex.org/W2519510391","https://openalex.org/W2626446274","https://openalex.org/W2900413769","https://openalex.org/W2939222610","https://openalex.org/W2974260792","https://openalex.org/W3034408257","https://openalex.org/W3127371223","https://openalex.org/W3129305070","https://openalex.org/W3138431202","https://openalex.org/W3177122952","https://openalex.org/W4200316324","https://openalex.org/W4206445899","https://openalex.org/W4313531093","https://openalex.org/W4388592674","https://openalex.org/W4394874190","https://openalex.org/W4398781461","https://openalex.org/W4399331171","https://openalex.org/W4409159939"],"related_works":["https://openalex.org/W7155375249","https://openalex.org/W7215123998","https://openalex.org/W7167418534","https://openalex.org/W7148720531","https://openalex.org/W7154007007","https://openalex.org/W7097051319","https://openalex.org/W4414767663","https://openalex.org/W4308447823","https://openalex.org/W7205709499","https://openalex.org/W7214355500"],"abstract_inverted_index":{"Aging":[0],"is":[1,44],"a":[2,47,160],"systems-level":[3],"process":[4],"linking":[5],"metabolic":[6,147,171,192],"dysfunction,":[7],"inflammation,":[8],"impaired":[9],"repair,":[10],"frailty,":[11],"and":[12,67,79,83,92,107,117,136,157,159,172,194,208,229,237],"multimorbidity,":[13],"whereas":[14],"existing":[15],"pharmacological":[16],"strategies":[17],"usually":[18],"optimize":[19],"disease-specific":[20],"endpoints":[21],"such":[22],"as":[23,46],"weight":[24,132],"loss":[25],"or":[26],"HbA1c":[27,134,162],"rather":[28],"than":[29],"aging-related":[30,204],"trajectories.":[31],"We":[32],"developed":[33],"an":[34],"SBML-compliant":[35],"quantitative":[36],"systems":[37],"pharmacology":[38],"(QSP)":[39],"model":[40,53,125,129],"in":[41],"which":[42],"aging":[43,71,173,209],"represented":[45],"dynamic,":[48],"pharmacologically":[49],"modifiable":[50],"endpoint.":[51],"The":[52,97,127],"integrates":[54],"four":[55],"coupled":[56],"layers:":[57],"metabolic/pharmacodynamic":[58],"responses":[59],"to":[60,123,243],"GLP-1":[61,183,195],"receptor":[62,184,196],"agonism,":[63],"SGLT2":[64,155,187,199],"inhibition,":[65],"metformin":[66,190],"rapamycin;":[68],"adverse-event":[69],"dynamics;":[70],"states":[72],"including":[73,86],"damage":[74],"accumulation,":[75],"repair":[76],"capacity,":[77],"frailty":[78],"biological":[80],"age":[81],"gap;":[82],"biomarker":[84],"outputs":[85],"GDF15,":[87],"cystatin":[88],"C,":[89],"leptin,":[90],"adiponectin":[91],"estimated":[93],"glucose":[94],"disposal":[95],"rate.":[96],"semaglutide":[98],"submodel":[99],"was":[100],"calibrated":[101,128],"against":[102,233],"published":[103],"STEP":[104],"trial":[105],"endpoints,":[106],"Bayesian":[108,143],"hierarchical":[109],"meta-analysis,":[110],"global":[111],"sensitivity":[112],"analysis,":[113],"practical":[114],"identifiability":[115],"analysis":[116,167],"internal":[118],"consistency":[119],"checks":[120],"were":[121],"used":[122],"assess":[124],"behavior.":[126],"reproduced":[130],"semaglutide-associated":[131],"loss,":[133],"reduction":[135],"transient":[137],"nausea":[138],"within":[139],"pre-specified":[140],"error":[141],"benchmarks.":[142],"meta-analysis":[144],"confirmed":[145],"strong":[146],"effects":[148,153],"for":[149,154,164,191,203],"semaglutide,":[150],"moderate":[151],"glycaemic":[152],"inhibitors":[156],"metformin,":[158],"near-zero":[161],"effect":[163],"rapamycin.":[165],"Sensitivity":[166],"revealed":[168],"largely":[169],"orthogonal":[170],"parameter":[174],"spaces.":[175],"Combination":[176],"simulations":[177],"identified":[178],"two":[179],"mechanistically":[180,213],"distinct":[181,214],"optima:":[182],"agonist":[185,197],"plus":[186,189,198,201],"inhibitor":[188,200],"improvement,":[193],"rapamycin":[202],"benefit.":[205],"Metabolic":[206],"optimisation":[207,210],"are":[211,227],"therefore":[212],"objectives":[215],"that":[216],"do":[217],"not":[218],"converge":[219],"on":[220],"the":[221],"same":[222],"drug":[223],"combination.":[224],"These":[225],"predictions":[226],"hypothesis-generating":[228],"require":[230],"external":[231],"validation":[232],"independent":[234],"longitudinal":[235],"datasets":[236],"clinical":[238],"safety":[239],"evaluation":[240],"before":[241],"translation":[242],"treatment":[244],"recommendations.":[245]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-08-10T00:00:00"}